Literature DB >> 35575924

HDL and ASCVD.

Hongtu Cui1, Qian Du2.   

Abstract

In this chapter, we summarize the relationship between circulating high-density lipoprotein (HDL) and atherosclerotic cardiovascular disease (ASCVD). HDL acts in many types of cells, such as endothelial cell, macrophage, T lymphocyte, etc. Recently, novel HDL-related therapies have been developed to treat ASCVD.
© 2022. Springer Nature Singapore Pte Ltd.

Entities:  

Keywords:  Atherosclerotic cardiovascular disease (ASCVD); High-density lipoprotein (HDL); Molecular mechanism

Mesh：

Substances：

Year:  2022        PMID： 35575924     DOI： 10.1007/978-981-19-1592-5_8

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN： 0065-2598            Impact factor:   2.622


  46 in total

1.  Effect of open-label infusion of an apoA-I-containing particle (CER-001) on RCT and artery wall thickness in patients with FHA.

Authors:  Ruud S Kootte; Loek P Smits; Fleur M van der Valk; Jean-Louis Dasseux; Constance H Keyserling; Ronald Barbaras; John F Paolini; Raul D Santos; Theo H van Dijk; Geesje M Dallinga-van Thie; Aart J Nederveen; Willem J M Mulder; G Kees Hovingh; John J P Kastelein; Albert K Groen; Erik S Stroes
Journal:  J Lipid Res       Date:  2015-01-05       Impact factor: 5.922

2.  Impaired regulatory T-cell response and enhanced atherosclerosis in the absence of inducible costimulatory molecule.

Authors:  Israel Gotsman; Nir Grabie; Rajat Gupta; Rosa Dacosta; Malcolm MacConmara; James Lederer; Galina Sukhova; Joseph L Witztum; Arlene H Sharpe; Andrew H Lichtman
Journal:  Circulation       Date:  2006-10-23       Impact factor: 29.690

3.  Association of an HDL Apolipoproteomic Score With Coronary Atherosclerosis and Cardiovascular Death.

Authors:  Pradeep Natarajan; Tim S Collier; Zhicheng Jin; Asya Lyass; Yiwei Li; Nasrien E Ibrahim; Renata Mukai; Cian P McCarthy; Joseph M Massaro; Ralph B D'Agostino; Hanna K Gaggin; Cory Bystrom; Marc S Penn; James L Januzzi
Journal:  J Am Coll Cardiol       Date:  2019-05-07       Impact factor: 24.094

4.  The effect of an apolipoprotein A-I-containing high-density lipoprotein-mimetic particle (CER-001) on carotid artery wall thickness in patients with homozygous familial hypercholesterolemia: The Modifying Orphan Disease Evaluation (MODE) study.

Authors:  G Kees Hovingh; Loek P Smits; Claudia Stefanutti; Handrean Soran; See Kwok; Jacqueline de Graaf; Daniel Gaudet; Constance H Keyserling; Heather Klepp; Jennifer Frick; John F Paolini; Jean-Louis Dasseux; John J P Kastelein; Erik S Stroes
Journal:  Am Heart J       Date:  2015-01-28       Impact factor: 4.749

5.  Dynamic changes in regulatory T cells are linked to levels of diet-induced hypercholesterolemia.

Authors:  Elena Maganto-García; Margarite L Tarrio; Nir Grabie; De-xiu Bu; Andrew H Lichtman
Journal:  Circulation       Date:  2011-06-20       Impact factor: 29.690

Review 6.  Cholesterol crystal induced arterial inflammation and destabilization of atherosclerotic plaque.

Authors:  Abed Janoudi; Fadi E Shamoun; Jagadeesh K Kalavakunta; George S Abela
Journal:  Eur Heart J       Date:  2015-12-24       Impact factor: 29.983

7.  Desmocollin 1 is abundantly expressed in atherosclerosis and impairs high-density lipoprotein biogenesis.

Authors:  Hong Y Choi; Isabelle Ruel; Abba Malina; David R Garrod; Michael N Oda; Jerry Pelletier; Adel Schwertani; Jacques Genest
Journal:  Eur Heart J       Date:  2018-04-07       Impact factor: 29.983

8.  Thermogenic adipocytes promote HDL turnover and reverse cholesterol transport.

Authors:  Alexander Bartelt; Clara John; Nicola Schaltenberg; Jimmy F P Berbée; Anna Worthmann; M Lisa Cherradi; Christian Schlein; Julia Piepenburg; Mariëtte R Boon; Franz Rinninger; Markus Heine; Klaus Toedter; Andreas Niemeier; Stefan K Nilsson; Markus Fischer; Sander L Wijers; Wouter van Marken Lichtenbelt; Ludger Scheja; Patrick C N Rensen; Joerg Heeren
Journal:  Nat Commun       Date:  2017-04-19       Impact factor: 14.919

9.  Brown fat activation reduces hypercholesterolaemia and protects from atherosclerosis development.

Authors:  Jimmy F P Berbée; Mariëtte R Boon; P Padmini S J Khedoe; Alexander Bartelt; Christian Schlein; Anna Worthmann; Sander Kooijman; Geerte Hoeke; Isabel M Mol; Clara John; Caroline Jung; Nadia Vazirpanah; Linda P J Brouwers; Philip L S M Gordts; Jeffrey D Esko; Pieter S Hiemstra; Louis M Havekes; Ludger Scheja; Joerg Heeren; Patrick C N Rensen
Journal:  Nat Commun       Date:  2015-03-10       Impact factor: 14.919

10.  Apolipoprotein AI prevents regulatory to follicular helper T cell switching during atherosclerosis.

Authors:  Dalia E Gaddis; Lindsey E Padgett; Runpei Wu; Chantel McSkimming; Veronica Romines; Angela M Taylor; Coleen A McNamara; Mitchell Kronenberg; Shane Crotty; Michael J Thomas; Mary G Sorci-Thomas; Catherine C Hedrick
Journal:  Nat Commun       Date:  2018-03-15       Impact factor: 14.919
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.